- Report
- May 2024
- 133 Pages
Global
From €6071EUR$6,499USD£5,136GBP
- Report
- June 2024
- 200 Pages
Global
From €7427EUR$7,950USD£6,283GBP
- Report
- January 2022
- 60 Pages
Global
From €3690EUR$3,950USD£3,122GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2022
- 94 Pages
Global
From €1868EUR$2,000USD£1,581GBP
The Polio Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat and prevent polio, a highly contagious viral infection that can cause paralysis and even death. Polio drugs are typically administered orally or by injection, and can be used to treat both acute and chronic cases of the disease. The most common polio drugs are inactivated poliovirus vaccine (IPV), oral poliovirus vaccine (OPV), and monoclonal antibodies.
The Polio Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Sanofi, GlaxoSmithKline, Merck, Pfizer, and Novartis. Other companies such as Emergent BioSolutions, Emergent Vaccines, and Bharat Biotech are also active in the market. Show Less Read more